3.2m signed up for Sinopharm jabs, Thailand’s mRNA vaccine candidate enters human trials

1 min read

BANGKOK (NNT) – Thailand’s provider of Sinopharm vaccine has seen 3.2 million people sign up for the alternative offering in the government’s main vaccination drive, while Thailand’s homegrown mRNA COVID-19 vaccine has entered human trials.

Chulabhorn Royal Academy (CRA), the sole provider of Sinopharm COVID-19 vaccine in Thailand as an alternative offering to the government’s national inoculation campaign announced it has received a list of 3,182,006 million people who wish to get Sinopharm jabs, sent via 6,938 organizations.

With the vaccine requiring a 2-dose regimen, the academy would need a supply of more than 6 million doses to serve all the people signed up.

Full story: National News Bureau of Thailand

Reporter: Tanakorn Sangiam,
Rewriter: Tarin Angskul
National News Bureau of Thailand


The main purpose of Thailand News is to offer our readers all news from the most popular and trusted newspapers in Thailand & Asia in one place.

Get breaking news and the latest news headlines from Bangkok, Phuket, Pattaya, Chiang Mai, Northern Thailand, Isan, the insurgency-plagued South and Asia.

You May Also Like

More From Author

+ There are no comments

Add yours

Leave a Reply